Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy | Zendy

Abel Kakuru | Zendy; Prasanna Jagannathan | Zendy; Mary Muhindo | Zendy; Paul Natureeba | Zendy; Patricia Awori | Zendy; Miriam Nakalembe | Zendy; Bishop Opira | Zendy; Peter Olwoch | Zendy; John Ategeka | Zendy; Patience Nayebare | Zendy; Tamara D. Clark | Zendy; Margaret E. Feeney | Zendy; Edwin D. Charlebois | Zendy; Gabrielle Rizzuto | Zendy; Atis Muehlenbachs | Zendy; Diane V. Havlir | Zendy; Moses R. Kamya | Zendy; Grant Dorsey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

Author(s) -

Abel Kakuru,

Prasanna Jagannathan,

Mary Muhindo,

Paul Natureeba,

Patricia Awori,

Miriam Nakalembe,

Bishop Opira,

Peter Olwoch,

John Ategeka,

Patience Nayebare,

Tamara D. Clark,

Margaret E. Feeney,

Edwin D. Charlebois,

Gabrielle Rizzuto,

Atis Muehlenbachs,

Diane V. Havlir,

Moses R. Kamya,

Grant Dorsey

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1509150

Subject(s) - piperaquine , dihydroartemisinin , malaria prevention , malaria , medicine , pregnancy , obstetrics , artemisinin , environmental health , plasmodium falciparum , biology , immunology , population , genetics , health services

Intermittent treatment with sulfadoxine-pyrimethamine is widely recommended for the prevention of malaria in pregnant women in Africa. However, with the spread of resistance to sulfadoxine-pyrimethamine, new interventions are needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research